View Post

Uncomplicated Urinary Tract Infection Tablets Approved in the U.S.

In COVID-19, Latest News by Precision Vaccinations

For decades, antibiotics have been a mainstay of treatments for urinary tract infections (UTIs). Still, the growing threat of antibiotic resistance has limited clinicians' options to control infections effectively.
A 2022 World Health Organization surveillance report found that the most common cause of UTIs is resistance to first—and second-line antibiotics.
Research indicates that 40% of women in the United States will develop a UTI at some point in their lifetime.

View Post

UK Confirms 32% Increase in Malaria Cases

In COVID-19, Latest News by Precision Vaccinations

In recognition of World Malaria Day 2024, various countries are reporting increased cases related to international travelers and actions to prevent further outbreaks.
The World Health Organisation (WHO) recently reported that global malaria cases were estimated at 249 million in 2022, an increase of about 2% from 2021.

View Post

Vaccination Efforts Saved Over 154 Million Lives

In COVID-19, Latest News by Precision Vaccinations

A study published today by The Lancet has revealed that global immunization efforts have saved an estimated 154 million lives over the past 50 years.
Most lives saved were those of infants, with 101 million lives saved.
The study, led by the World Health Organization (WHO), found that vaccination against 14 diseases has reduced infant deaths by 40% globally.

View Post

US FDA Approves IL-15 Superagonist for Treating Bladder Cancer

In COVID-19, Latest News by Precision Vaccinations

For several decades, a century-old vaccine has been used to treat a specific type of bladder cancer. In the 1970s, the Bacillus Calmette-Guérin (BCG) vaccine was approved as an immunotherapeutic treatment for bladder cancer patients.
Since then, various BCG vaccines have become the standard therapy for treating high-risk nonmuscle-invasive bladder cancer (NMIBC) patients to prevent the recurrence and progression of the disease.

View Post

Oral Cancer Month Encourages More HPV Vaccinations

In COVID-19, Latest News by Precision Vaccinations

In April 2024, the United States observes the 15th Annual Oral Cancer Awareness Month, which emphasizes the significance of preventing human papillomavirus (HPV)- related oral cancers.
Projections estimate an upward trend for the next decade, with predictions greater than 30,000 oral cancer cases annually by 2029.
Research shows that more than 90% of oropharyngeal cancer cases are linked to HPV 16.
As of 2023, oropharyngeal and oral cavity cancers impact far more men than women.

View Post

Adult Vaccinations Produce 19 to 1 ROI

In COVID-19, Latest News by Precision Vaccinations

In recent times, the pandemic highlighted contagious diseases that affect older individuals, leading to an increased burden of costly hospitalization.
One proven tactic to prevent disease is vaccination.
A recent study across 10 countries revealed that adult immunization programs can generate a return of up to 19 times their initial investment when considering the full range of benefits. 
This study calculated the equivalent of billions of dollars in net monetary benefits to society or, more concretely, up to $4,637 for one individual's entire vaccination course.

View Post

300 Measles Cases Forecasted in 2024

In COVID-19, Latest News by Precision Vaccinations

Over the past two decades, most measles cases have been related to infected, unvaccinated international travelers bringing the highly transmissible virus with them to the United States.
This year, the U.S. is at greater risk for measles outbreaks because 49 countries are reporting cases, and international travel has resumed full throttle.
For example, a significant international measles outbreak continues in India. 

View Post

UTI Vaccine Only Available to Travelers

In COVID-19, Latest News by Precision Vaccinations

Many women have learned Recurrent Urinary Tract Infections (rUTIs) can be challenging to treat with antibiotics. However, an innovative oral spray-based vaccine called Uromune™ (MV140) has been found to be a viable alternative treatment.
Improved non-antibiotic management of rUTI in women represents a genuine, unmet, global medical need, stated researchers in a new study.